Nalaganje...
WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
Philadelphia (Ph*)/BCR-ABL1-positive chronic myeloid leukemia (CML) is considered as a chronic life-long disease, which could be manageable with tyrosine kinase inhibitor (TKI) drugs. The aim of TKI drug treatment is to provide age- and sex-matched duration of life in a given patient with CML. Perso...
Shranjeno v:
| izdano v: | Turk J Haematol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Galenos Publishing
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7057757/ https://ncbi.nlm.nih.gov/pubmed/31612694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.galenos.2019.2019.0241 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|